RecruitingNCT06104852

Triage Survey for Neurology Research Eligibility

Sponsor

Adams Clinical

Enrollment

600 participants

Start Date

Jun 2, 2023

Study Type

OBSERVATIONAL

Conditions

Alzheimer Disease

Summary

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
Participant and study partner (when applicable) are at least 18 years old.

Exclusion Criteria7

Participant lacks the language skills or cognitive ability to understand the screening process.
Participant is pregnant, breast-feeding, or planning to become pregnant.
History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
Any condition that in the investigator's opinion makes a participant unsuitable for the study.
Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.

Interventions

OTHERSurvey

Participants will be surveyed on demographics, medical history, and current memory and cognitive concerns. Vitals signs, urine drug screen, blood draw may be collected.

OTHEROptional Medication Washout

Participants taking memory medications which require a down-taper per the judgment of the study physicians may participate in a medication washout period during study screening.